AMI Asset Management Corp Has $18.86 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

AMI Asset Management Corp reduced its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 32.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 75,649 shares of the medical technology company's stock after selling 35,896 shares during the period. AMI Asset Management Corp owned about 0.16% of Teleflex worth $18,862,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the company. Washington Capital Management Inc. acquired a new stake in Teleflex in the 4th quarter valued at about $549,000. LGT Capital Partners LTD. lifted its position in Teleflex by 285.4% during the fourth quarter. LGT Capital Partners LTD. now owns 257,864 shares of the medical technology company's stock worth $64,296,000 after acquiring an additional 190,950 shares during the last quarter. Schechter Investment Advisors LLC acquired a new stake in Teleflex during the fourth quarter worth approximately $222,000. Raymond James & Associates lifted its position in Teleflex by 10.5% during the fourth quarter. Raymond James & Associates now owns 126,227 shares of the medical technology company's stock worth $31,473,000 after acquiring an additional 11,943 shares during the last quarter. Finally, Raymond James Trust N.A. increased its holdings in shares of Teleflex by 6.0% during the fourth quarter. Raymond James Trust N.A. now owns 2,668 shares of the medical technology company's stock worth $665,000 after purchasing an additional 150 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Teleflex

In related news, VP Cameron P. Hicks sold 7,401 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares in the company, valued at $2,261,250. The transaction was disclosed in a document filed with the SEC, which is available through this link. 1.41% of the stock is owned by company insiders.

Teleflex Trading Up 1.0 %

Shares of NYSE:TFX traded up $2.30 during mid-day trading on Friday, reaching $226.17. 288,953 shares of the company's stock were exchanged, compared to its average volume of 279,478. The firm has a market capitalization of $10.64 billion, a price-to-earnings ratio of 30.04, a PEG ratio of 2.17 and a beta of 1.11. The business's fifty day moving average price is $235.35 and its 200-day moving average price is $224.20. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $276.43.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, topping analysts' consensus estimates of $3.26 by $0.12. The company had revenue of $773.90 million for the quarter, compared to analyst estimates of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. Teleflex's revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.52 earnings per share. On average, research analysts predict that Teleflex Incorporated will post 13.73 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were issued a $0.34 dividend. The ex-dividend date was Thursday, February 29th. This represents a $1.36 annualized dividend and a yield of 0.60%. Teleflex's payout ratio is 18.06%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on TFX. Raymond James lifted their price objective on shares of Teleflex from $227.00 to $271.00 and gave the company an "outperform" rating in a research note on Wednesday, December 20th. Morgan Stanley raised shares of Teleflex from an "equal weight" rating to an "overweight" rating and set a $261.00 price objective on the stock in a research note on Monday, December 4th. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 23rd. Truist Financial decreased their target price on shares of Teleflex from $270.00 to $265.00 and set a "hold" rating on the stock in a research note on Friday, February 23rd. Finally, Royal Bank of Canada decreased their target price on shares of Teleflex from $272.00 to $265.00 and set an "outperform" rating on the stock in a research note on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $265.56.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.